| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Browall, Maria, et al.
(författare)
-
The course of health related quality of life in postmenopausal women with breast cancer from breast surgery and up to five years post-treatment
- 2013
-
Ingår i: European Journal of Cancer. - Oxon, United Kingdom : Elsevier. - 0959-8049 .- 1879-0852. ; 49, s. S344-S345
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Cancer treatment of the elderly patients is an increasingly important concern since the risk for developing breast cancer increases with age. The effects of adjuvant chemotherapy on the breast cancer disease seem to be as good for pre and postmenopausal patients, at least for hormone receptor negative patients. However, very few patients older than 65 years are included in randomised studies. In clinical practice, it is common that elderly women are offered less chemotherapy, because of the unsubstantiated belief that they will experience a larger number and more severe adverse effects as well as poor functional outcomes and significant decrements in health related quality of life (HRQOL). The aim of this study was to follow HRQOL in postmenopausal women (55−80 years) with breast cancer receiving adjuvant treatment after surgery, until five years post-treatment, and compare with a general population.Patients and Methods: The patient sample included 150 women (adjuvant CT n = 75 and RT n = 75) and two reference samples from the Swedish SF- 36 norm database.Results: The results showed that at baseline the women in the patient sample experienced significantly higher levels of physical functioning and general health compared to the general population. They also experienced significantly less bodily pain, lower emotional role functioning and mental health. Five years after completion of treatment, the patient sample experienced better HRQOL than the reference sample in all domains, supporting our hypothesis that the impact on HRQOL would have been resolved over time for these patients. Conclusion: Postmenopausal women (55−80 years) seem to successfully manage the effects of adjuvant treatment on HRQOL.
|
|
| 9. |
- Eicher, Manuela, et al.
(författare)
-
Training breast care nurses throughout Europe : the EONS post basic curriculum for breast cancer nursing
- 2012
-
Ingår i: European Journal of Cancer. - : Elsevier BV. - 0959-8049 .- 1879-0852. ; 48:9, s. 1257-1262
-
Tidskriftsartikel (refereegranskat)abstract
- Background: The European Parliamentary Group on Breast Cancer and the European Society of Breast Cancer Specialists state that there is a need for EU agreed guidelines on breast care nursing and training. Therefore the European Oncology Nursing Society (EONS) commissioned the development of a post-basic curriculum for breast cancer nursing. Purpose: The goal was to define a European curriculum for the training of breast care nurses. Methods: The curriculum was developed using a variety of sources, including guidelines from a number of European and other countries world wide, relevant literature and input from an expert panel of senior European nurses with expertise in breast care nursing. Results: An English language, European curriculum of breast care nursing was developed at a postbasic level to provide guidance for the training of breast care nurses throughout Europe. Definitions for breast care nurse roles and activities and levels of practice, as well as indicative content are provided. Conclusions: The training of nurses in breast cancer care should be mandatory and common practice for European countries. To enhance comparability and standard development, the indicative content should be applied in all future post-basic education. (C) 2011 Elsevier Ltd. All rights reserved.
|
|
| 10. |
- Kotronoulas, Grigorios, et al.
(författare)
-
Dyadic sleep/wake assessments in cancer care : new insight from a longitudinal study among women with breast cancer and their informal caregivers during adjuvant chemotherapy
- 2013
-
Ingår i: European Journal of Cancer. - 0959-8049 .- 1879-0852. ; 49, s. S379-S380
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Alterations in habitual sleep/wake patterns (SWP) of women with breast cancer and their informal caregivers may be concurrently exacerbated and co-vary during the patient’s treatment. Taking into consideration the complexity of mechanisms interfering with a care dyad’s sleep, the current study set out to longitudinally explore SWP of patientcaregiver dyads in the context of adjuvant chemotherapy (CTh) for breast cancer.Material and Methods: In this descriptive, observational, repeatedmeasures dyadic study, 48 newly diagnosed women receiving outpatient adjuvant CTh for early stage breast cancer (stage I−IIIA), and their nominated primary informal caregiver completed self-reported sleep measures at pre-treatment (week prior to CTh), post-CTh cycle 1, post- CTh cycle 4, and approximately 30 days after CTh (total of 6 cycles received). Multivariate hierarchical linear modelling (MHLM) techniques were implemented to analyse dyadic sleep data.Results: Prior to CTh, 65% of dyads consisted of at least one poor sleeper, a rate further increasing to approximately 88% at CThC4. MHLM revealed curvilinear trajectories for most of dyads’ sleep/wake parameters that nevertheless reached significance (p <. 05) only for patients. In both groups, sleep/wake impairment reached its peak at mid-treatment (CThC4); yet, patients consistently reported significantly more sleep problems than their carers. Partial convergence also emerged as suggested by positive correlations and no between-groups differences in daily disturbance, daytime napping duration (NAPTIME), total sleep time, and overall sleep/ wake disruption at pre-treatment. At CThC4, rates of change in sleep latency and NAPTIME were alsosimilar.Conclusions: The current study is one of the first studies to show that a dyadic approach in the assessment of SWP in patients with breast cancer and their carers is a promising method to enhance exploration of potentially concurrent sleep-impairment. Replication of the current findings in future dyadic sleep research is an absolute priority. Meanwhile, clinicians will need to engage in concurrent systematic and on-going sleep assessments that synthesise and contrast data to establish a care dyad’s level of sleep quality.
|
|
